Targeted therapy of lung cancer-data from Asia
- VernacularTitle:肺癌靶向治疗——来自亚洲的数据
- Author:
Shun LU
;
Ziming LI
- Publication Type:Journal Article
- Keywords:
targeted therapy;
lung neoplasms
- From:
China Oncology
1998;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
3 months. Female gender, adenocarcinoma history, non-smoking history, good PS and the presence of multiple lung metastases are associated with improved responsiveness to Gefitinib. Reflecting the results of previous clinical trials, the reports indicate that Gefitinib is generally well tolerated by Asian patients. The incidence of interstitial lung disease appears to be higher in Japanese than non-Japanese patients, although the reason for this is not clear. Recent findings regarding Erlotinib and other targeted therapy among Asian patients are discussed.
